Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2025-2031

Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2025-2031

The global Natural Killer Cell Therapy market size is predicted to grow from US$ 385 million in 2025 to US$ 1475 million in 2031; it is expected to grow at a CAGR of 25.1% from 2025 to 2031.

Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

LPI (LP Information)' newest research report, the “Natural Killer Cell Therapy Industry Forecast” looks at past sales and reviews total world Natural Killer Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Natural Killer Cell Therapy sales for 2025 through 2031. With Natural Killer Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Natural Killer Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
NK Cell Therapies
NK Cell Directed Antibodies

Segmentation by Application:
Cancer
Gastrointestinal Diseases
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

Please note: The report will take approximately 2 business days to prepare and deliver.